Özet:

Primary non-Hodgkin lymphoma is a rare disease1-13. It accounts for 1-9 percent of all testicular malignities and about 1-2 percent of all non-Hodgkin lymphomas2,4,7,8,10,13. Despite its rare appearance, the testicular malignity that is seen over the age of 60 is 2-8,13. It is usually found in older ages. The average age is 60 to 68. The diagnosis is diagnosed histopathologically3.11. Diffuse large B cell lymphoma (DBBHL) is a common histological subtype1-6,10-13. The important parameters determining the prognosis are the stage and histological degree. The prognosis is worse than other testicular tumors, and the absence of the outcome of spread within the first 1 year is considered a good prognosis sign1-6,9. While testicular holding is more common in common nodal lymphomas, primary lymphoma of testicular is rare. 57% of primary testicular lymphoma occur in phase I, 22% in phase II and 21% in phase III-IV. Although there is no standard treatment available, especially in early stages of disease, in stages I and II of disease, the use of post-orchiektomy dosorubicine or antrasiclinic chemotherapy is recommended7.8. Advanced stage (Ease III and IV) is the preferred treatment method of combined-ion chemotherapy in the disease1.2. This article aims to discuss the clinic pathological findings of the phenomenon receiving rare PTL diagnosis along with literary information.